The Cardiology Highlight Reel 2015 series engages world-renowned experts in conversation about the most important advances in cardiovascular medicine in 2015. Presented in short interviews, this program is a must-see for all clinicians managing patients with, or at risk for, cardiovascular disease.

In this segment, Dr. Jim Douketis discusses bridging warfarin, real-world data with NOAC’s, and the introduction of the first NOAC reversal agent.

Participate in this eCME program and stay informed!

Cardiology Highlight Reel program flyer

AF / Thrombosis program flyer

This activity has not been reviewed by the CFPC; however, Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.

You will receive your Certificate of Completion following participation in the interactive program elements located under the “Certificate” tab in the program player window.  A link to the Linking Learning to Practice exercise on the CFPC website will be included in your certificate.

Some speakers in this program have received payment/funding from the organizations supporting this program.
Speaker disclosures will be declared within the presentations.

	Co-Chair Milan Gupta, MD, FRCPC, FACC Associate Clinical Professor, Dep’t of Medicine McMaster UniversityAssistant Professor, Dep’t of Medicine University of TorontoMedical Director Canadian Cardiovascular Research Network	Brampton, ON
	Co-Chair Narendra Singh, MD, FRCPC, FACC, FAHA Director, Clinical Research Atlanta Heart SpecialistsClinical Assistant Professor Georgia Regents University	Atlanta, GA
	Guest Faculty James Douketis, MD Professor, Division of Hematology and Thromboembolism, Department of Medicine St. Joseph’s HospitalAssociate Director, Clinical Teaching Unit St. Joseph’s HospitalStaff Physician, Clinical Thromboembolism and General Internal Medicine Services St. Joseph’s Hospital	Hamilton, ON

• Amgen Canada
• AstraZeneca Canada
• Boehringer Ingelheim Canada
• Sanofi Canada